213 A Phase Ii Study of Etanercept (ENBREL), A Tumour Necrosis Factor-Alpha Inhibitor in Recurrent Ovarian CancerSrinivasan Madhusudan, Trivadi S. Ganesan, Kanchan Kaur et al.|International Journal of Gynecological Cancer|2004Cited by 1
A phase II trial using etanercept, a recombinant tumour necrosis factor antagonist, in metastatic breast cancerFörster, Adrian L. Harris, Jeremy Braybrooke et al.|UCL Discovery (University College London)|2002Cited by 1